Skip to main content
FDA Shortage Check

Is Rocuronium Bromide Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Rocuronium Bromide Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Delay in shipping of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated recovery: TBD”. Manufacturer’s estimate, Fresenius Kabi USA, LLC, Oct 15, 2026
DRUG
Rocuronium Bromide Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Feb 15, 2023
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 26 presentations: 4 unavailable · 1 limited · 21 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Rocuronium Bromide Injection. 26 presentations from 11 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Fresenius Kabi USA, LLC5 presentations · 4 unavailable · 1 available or not stated

Contact (FDA's listing): 888-386-1300

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)

    Next release December 2026. Check wholesalers for inventory.

    NDC 63323-426-05Revised

    Unavailable

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)

    Estimated recovery: TBD

    NDC 65219-065-05Reverified

    Unavailable

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)

    Next release November 2026. Check wholesalers for inventory.

    NDC 65219-442-05Revised

    Unavailable

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)

    Next release November 2026. Check wholesalers for inventory.

    NDC 65219-444-10Reverified

    Unavailable

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)

    Check wholesalers for inventory

    NDC 63323-426-10Reverified

    Available

Piramal Critical Care Inc.2 presentations · 1 limited · 1 available or not stated

Contact (FDA's listing): 800-414-1901

  • 100 mg/10 mL

    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)

    On allocation

    NDC 66794-229-41Reverified

    Limited Availability

  • 50 mg/5 mL

    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)

    NDC 66794-228-41Revised

    Available

Baxter Healthcare2 presentations · 2 available or not stated

Contact (FDA's listing): 888-229-0001

  • 100 mg/10 mL

    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)

    NDC 43066-013-10Reverified

    Available

  • 50 mg/5 mL

    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)

    NDC 43066-007-10Reverified

    Available

Eugia US LLC2 presentations · 2 available or not stated

Contact (FDA's listing): 888-238-7880

  • 100 mg/10 mL

    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)

    Check wholesalers for inventory

    NDC 55150-226-10Reverified

    Available

  • 50 mg/5 mL

    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)

    Check wholesalers for inventory

    NDC 55150-225-05Reverified

    Available

Hikma Pharmaceuticals USA, Inc.2 presentations · 2 available or not stated

Contact (FDA's listing): 800-631-2174

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)

    Additional lots will be available. Product will be made available as it is released.

    NDC 0143-9250-10Reverified

    Available

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)

    Additional lots will be available. Product will be made available as it is released.

    NDC 0143-9251-10Reverified

    Available

Hospira, Inc., a Pfizer Company4 presentations · 4 available or not stated

Contact (FDA's listing): 844-646-4398

  • 100 mg/10 mL (10 mg/mL)

    Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)

    NDC 0409-5160-10Reverified

    Available

  • 100 mg/10 mL (10 mg/mL)

    Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)

    NDC 0409-7037-10Reverified

    Available

  • 50 mg/5 mL (10 mg/mL)

    Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)

    NDC 0409-1403-10Reverified

    Available

  • 50 mg/5 mL (10 mg/mL)

    Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)

    NDC 0409-3189-10Reverified

    Available

Meitheal Pharmaceuticals, Inc.2 presentations · 2 available or not stated

Contact (FDA's listing): 844-824-8426

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)

    NDC 71288-700-06Reverified

    Available

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)

    NDC 71288-718-11Reverified

    Available

Mylan Institutional, a Viatris Company2 presentations · 2 available or not stated

Contact (FDA's listing): 800-796-9526

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)

    NDC 67457-228-05Reverified

    Available

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)

    NDC 67457-228-10Reverified

    Available

Sagent Pharmaceuticals1 presentation · 1 available or not stated

Contact (FDA's listing): 866-625-1618

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)

    NDC 25021-687-05Reverified

    Available

Sandoz Inc.2 presentations · 2 available or not stated

Contact (FDA's listing): 800-525-8747

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)

    NDC 0781-3220-92Reverified

    Available

  • 10 mg/1 mL

    Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)

    NDC 0781-3220-95Reverified

    Available

XGen Pharmaceuticals DJB, Inc.2 presentations · 2 available or not stated

Contact (FDA's listing): 866-390-4411

  • 100 mg/10 mL

    Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)

    Tamarang is the application holder and X-Gen is the distributor/labeler

    NDC 39822-4200-6Reverified

    Available

  • 50 mg/5 mL

    Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)

    Tamarang is the application holder and X-Gen is the distributor/labeler

    NDC 39822-4200-2Reverified

    Available

What the manufacturers told FDA

  • Fresenius Kabi USA, LLC · ‘Estimated recovery: TBD’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release December 2026. Check wholesalers for inventory.’ · updated Oct 2026
  • Fresenius Kabi USA, LLC · ‘Next release November 2026. Check wholesalers for inventory.’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Delay in shipping of the drug
  • Demand increase for the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Rocuronium Bromide Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Rocuronium Bromide Injection as currently in shortage: 26 presentations, 4 unavailable and 1 limited.
When will the Rocuronium Bromide Injection shortage end?
FDA gives no end date. 1 presentation carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Rocuronium Bromide Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.